Device Trial Radar · NCT03697980
Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform
Last checked: Nov 20, 2026Latest source record: Dec 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Jan 17, 2019
Primary completion
Feb 10, 2022
Study completion Feb 10, 2022
Sponsor
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
- Sponsor type
- Industry
- First posted
- Oct 5, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Medtronic is sponsoring the Apogee study to further enhance scientific understanding of the implant procedure, optimized blood pressure management, and anticoagulation/ antiplatelet therapy in patients receiving a Medtronic HeartWare™ Ventricular Assist Device (HVAD™) for destination therapy. The Apogee study is conducted within Medtronic's Product Surveillance Platform.
Conditions
- Chronic Heart Failure
Interventions
HeartWare Ventricular Assist DeviceDevice
The HVAD is an implantable centrifugal rotary blood pump that is implanted in the pericardial space and is designed to provide up to 10 L/min of blood flow from the left ventricular to the aorta. The HVAD System is comprised of three major components: the HVAD (pump) with inflow and outflow conduits, a Controller (microprocessor unit that controls the operation of the HVAD), and power sources (AC and DC power adapters that provide power to the Controller and implanted HVAD).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Major Adverse EventsTime frame: Implant to 12 months
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Saint Vincent Heart Clinic Arkansas
Little Rock, Arkansas
University of California San Diego
San Diego, California
University of California San Francisco Medical Center
San Francisco, California
30 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.